Kylie H Kang

3PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 03, 2021
A Pilot Study Examining the Prognostic Utility of Tumor Shrinkage on Cone-Beam Computed Tomography (CBCT) for Stage III Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation.

Kylie H Kang, Jimmy T Efird, Tarun K Podder

|Nov 04, 2020
Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC).

Tithi Biswas, Kylie H Kang, Rohin Gawdi

|Dec 19, 2019
Proton therapy for head and neck paragangliomas: A single institutional experience.

Kylie H Kang, Emily S Lebow, Andrzej Niemierko

Pageof 1

Frequent Collaborators

2 joint publications

Jimmy T Efird